OTCMKTS:PBSV - Pharma-Bio Serv Stock Price, Price Target & More

$0.45 -0.05 (-10.00 %)
(As of 04/19/2018 04:00 PM ET)
Previous Close$0.50
Today's Range$0.45 - $0.5001
52-Week Range$0.3250 - $0.70
Volume17,800 shs
Average Volume12,643 shs
Market Capitalization$10.38 million
P/E Ratio-7.50
Dividend YieldN/A
Beta0.39

About Pharma-Bio Serv (OTCMKTS:PBSV)

Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm with a laboratory testing facility in Puerto Rico, the United States, Europe, and Brazil markets. It provides compliance consulting services to the pharmaceutical, chemical, biotechnology, medical device, cosmetic, food industries, and allied products in Puerto Rico, the United States, Europe, and Brazil. The company's technical consulting services comprise regulatory compliance, validation, technology transfer, engineering, project management, and process support. It also offers microbiological and chemical testing services through its lab; and technical trainings/seminars. The company markets its services through industry trade shows, professional conventions, industry publications, and seminars. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico.

Receive PBSV News and Ratings via Email

Sign-up to receive the latest news and ratings for PBSV and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Management consulting services
Sub-IndustryN/A
SectorBusiness Services
SymbolOTCMKTS:PBSV
CUSIPN/A
Phone787-278-2709

Debt

Debt-to-Equity RatioN/A
Current Ratio13.30%
Quick Ratio13.30%

Price-To-Earnings

Trailing P/E Ratio-7.50
Forward P/E Ratio-3.75
P/E GrowthN/A

Sales & Book Value

Annual Sales$15.58 million
Price / Sales0.67
Cash FlowN/A
Price / CashN/A
Book Value$0.90 per share
Price / Book0.50

Profitability

EPS (Most Recent Fiscal Year)($0.06)
Net Income$-1,410,000.00
Net Margins-23.46%
Return on Equity-18.22%
Return on Assets-16.45%

Miscellaneous

Employees155
Outstanding Shares23,060,000

How to Become a New Pot Stock Millionaire

Pharma-Bio Serv (OTCMKTS:PBSV) Frequently Asked Questions

What is Pharma-Bio Serv's stock symbol?

Pharma-Bio Serv trades on the OTCMKTS under the ticker symbol "PBSV."

How were Pharma-Bio Serv's earnings last quarter?

Pharma-Bio Serv (OTCMKTS:PBSV) issued its earnings results on Monday, January, 29th. The company reported ($0.02) earnings per share (EPS) for the quarter. The firm earned $3.63 million during the quarter. Pharma-Bio Serv had a negative return on equity of 18.22% and a negative net margin of 23.46%. View Pharma-Bio Serv's Earnings History.

When is Pharma-Bio Serv's next earnings date?

Pharma-Bio Serv is scheduled to release their next quarterly earnings announcement on Friday, April, 20th 2018. View Earnings Estimates for Pharma-Bio Serv.

Who are some of Pharma-Bio Serv's key competitors?

Who are Pharma-Bio Serv's key executives?

Pharma-Bio Serv's management team includes the folowing people:
  • Ms. Elizabeth Plaza, Founder, Chairman & Sr. Strategic Consultant (Age 54)
  • Mr. Victor Sanchez, CEO, Pres & Pres of European Operations (Age 47)
  • Mr. Pedro J. Lasanta, CFO, VP of Fin. & Admin., Principal Accounting Officer and Sec. (Age 58)

Has Pharma-Bio Serv been receiving favorable news coverage?

News headlines about PBSV stock have been trending somewhat positive recently, Accern Sentiment Analysis reports. The research group rates the sentiment of media coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Pharma-Bio Serv earned a coverage optimism score of 0.09 on Accern's scale. They also assigned news articles about the company an impact score of 44.49 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the next several days.

How do I buy shares of Pharma-Bio Serv?

Shares of PBSV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Pharma-Bio Serv's stock price today?

One share of PBSV stock can currently be purchased for approximately $0.45.

How big of a company is Pharma-Bio Serv?

Pharma-Bio Serv has a market capitalization of $10.38 million and generates $15.58 million in revenue each year. The company earns $-1,410,000.00 in net income (profit) each year or ($0.06) on an earnings per share basis. Pharma-Bio Serv employs 155 workers across the globe.

How can I contact Pharma-Bio Serv?

Pharma-Bio Serv's mailing address is Pharma-Bio Serv Building Suite 6 Road 696, DORADO PR, 00646. The company can be reached via phone at 787-278-2709 or via email at [email protected]


MarketBeat Community Rating for Pharma-Bio Serv (PBSV)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  31 (Vote Outperform)
Underperform Votes:  36 (Vote Underperform)
Total Votes:  67
MarketBeat's community ratings are surveys of what our community members think about Pharma-Bio Serv and other stocks. Vote "Outperform" if you believe PBSV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PBSV will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Pharma-Bio Serv (OTCMKTS:PBSV) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
(Data available from 4/19/2016 forward)

Earnings

Pharma-Bio Serv (OTCMKTS:PBSV) Earnings History and Estimates Chart

Earnings by Quarter for Pharma-Bio Serv (OTCMKTS:PBSV)

Pharma-Bio Serv (OTCMKTS:PBSV) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20181$0.01$0.01$0.01
Q4 20181$0.00$0.00$0.00

Pharma-Bio Serv (OTCMKTS PBSV) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/20/2018        
1/29/2018Q4 2017($0.02)$3.63 millionViewN/AView Earnings Details
9/14/2017Q3 2017($0.01)($0.01)$4.15 million$3.98 millionViewN/AView Earnings Details
6/14/2017Q2 2017($0.01)($0.01)$4.29 million$3.92 millionViewN/AView Earnings Details
3/17/2017Q1 2017($0.01)($0.02)$4.63 million$4.05 millionViewN/AView Earnings Details
1/31/2017Q4 2016($0.02)$5.13 million$4.64 millionViewN/AView Earnings Details
9/14/2016Q3 2016$0.01($0.01)$5.46 million$4.87 millionViewN/AView Earnings Details
3/16/2016Q1 2016$0.01$0.02$5.89 million$4.90 millionViewN/AView Earnings Details
1/29/2016Q4 2015$0.02$5.88 millionViewN/AView Earnings Details
9/14/2015Q3 2015$0.02$0.02$5.68 million$6.18 millionViewN/AView Earnings Details
6/15/2015Q2 2015$0.02$0.02$6.18 million$5.44 millionViewN/AView Earnings Details
3/17/2015Q1 2015$0.03$0.01$6.21 million$5.88 millionViewN/AView Earnings Details
1/29/2015$0.03$0.04$7.09 million$7.14 millionViewN/AView Earnings Details
9/15/2014$0.02$0.03$7.37 million$6.84 millionViewN/AView Earnings Details
6/16/2014$0.05$0.01$7.51 million$6.58 millionViewN/AView Earnings Details
3/17/2014Q1 2014$0.03$7.01 millionViewN/AView Earnings Details
1/29/2014Q4 2013$0.05$8.79 millionViewN/AView Earnings Details
9/16/2013Q3 2013$0.05$0.05$8.56 million$8.36 millionViewN/AView Earnings Details
6/14/2013Q2 2013$0.06$8.26 millionViewN/AView Earnings Details
3/18/2013Q1 2013$0.05$7.65 millionViewN/AView Earnings Details
1/29/2013Q4 2012$0.05ViewN/AView Earnings Details
9/14/2012Q3 2012$0.06ViewN/AView Earnings Details
6/14/2012Q2 2012$0.05ViewN/AView Earnings Details
3/16/2012Q1 2012$0.05ViewN/AView Earnings Details
1/30/2012Q4 2011$0.04ViewN/AView Earnings Details
9/14/2011Q3 2011$0.07ViewN/AView Earnings Details
6/14/2011Q2 2011$0.02ViewN/AView Earnings Details
3/17/2011Q1 2011$0.02ViewN/AView Earnings Details
1/31/2011Q4 2010$0.01ViewN/AView Earnings Details
9/14/2010Q3 2010$0.01ViewN/AView Earnings Details
1/29/2010Q4 2009$0.01ViewN/AView Earnings Details
6/15/2009Q2 2009$0.01ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Pharma-Bio Serv (OTCMKTS:PBSV) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Pharma-Bio Serv (OTCMKTS PBSV) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 51.20%
Insider Trading History for Pharma-Bio Serv (OTCMKTS:PBSV)

Pharma-Bio Serv (OTCMKTS PBSV) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/11/2014Kirk Wheeler MichelDirectorSell9,170$2.06$18,890.20View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Pharma-Bio Serv (OTCMKTS PBSV) News Headlines

Source:
DateHeadline
Pharma-Bio Serv (PBSV) Downgraded to "Sell" at ValuEnginePharma-Bio Serv (PBSV) Downgraded to "Sell" at ValuEngine
www.americanbankingnews.com - April 18 at 1:24 PM
Pharma-Bio Serv Expected to Post Q3 2018 Earnings of $0.01 Per Share (PBSV)Pharma-Bio Serv Expected to Post Q3 2018 Earnings of $0.01 Per Share (PBSV)
www.americanbankingnews.com - April 9 at 1:52 AM
PBSV: Very Strong Q1 Results. Rapid Recovery from Hurricanes, Ramping European Consulting ActivityPBSV: Very Strong Q1 Results. Rapid Recovery from Hurricanes, Ramping European Consulting Activity
finance.yahoo.com - April 6 at 3:26 PM
Women In Bio Announces Appointment of Mary Thistle to the Board of Homology MedicinesWomen In Bio Announces Appointment of Mary Thistle to the Board of Homology Medicines
globenewswire.com - March 20 at 8:49 AM
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2018Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2018
finance.yahoo.com - March 20 at 8:49 AM
Pharma Bio Serv (PBSV) Upgraded to Hold at ValuEnginePharma Bio Serv (PBSV) Upgraded to Hold at ValuEngine
www.americanbankingnews.com - March 4 at 1:02 PM
Morning Technical Insight on These Biotech Stocks -- Bellicum Pharma, BioPharmX, bluebird bio, and Calithera BiosciencesMorning Technical Insight on These Biotech Stocks -- Bellicum Pharma, BioPharmX, bluebird bio, and Calithera Biosciences
www.bizjournals.com - March 2 at 8:25 AM
New Strong Sell Stocks for February 21stNew Strong Sell Stocks for February 21st
www.zacks.com - February 21 at 7:39 AM
Mid-Day Market Update: SolarEdge Technologies Gains Following Q4 Earnings Beat; Avid Bioservices Shares SlideMid-Day Market Update: SolarEdge Technologies Gains Following Q4 Earnings Beat; Avid Bioservices Shares Slide
www.nasdaq.com - February 15 at 3:22 PM
PBSV Weathers The Storm, Quick Operational Rebound Bodes Well For Full RecoveryPBSV Weathers The Storm, Quick Operational Rebound Bodes Well For Full Recovery
finance.yahoo.com - February 12 at 5:39 PM
IIROC Trading Resumption - TBPIIROC Trading Resumption - TBP
www.bizjournals.com - February 8 at 5:28 PM
IIROC Trading Resumption - TBPIIROC Trading Resumption - TBP
www.bizjournals.com - February 8 at 5:28 PM
Pharma-Bio Serv Announces Results for the Year...Pharma-Bio Serv Announces Results for the Year...
www.benzinga.com - January 30 at 8:05 AM
Pharma-Bio Serv Announces Results for the Year Ended October 31, 2017Pharma-Bio Serv Announces Results for the Year Ended October 31, 2017
finance.yahoo.com - January 30 at 8:05 AM
Bioremediation Technology & Services Market to Reach US$65.7 Bn by 2025, Globally: Transparency Market ResearchBioremediation Technology & Services Market to Reach US$65.7 Bn by 2025, Globally: Transparency Market Research
www.prnewswire.com - January 9 at 8:57 AM
Peregrine Pharma (PPHM) Changes to Avid Bioservices (CDMO)Peregrine Pharma (PPHM) Changes to Avid Bioservices (CDMO)
www.streetinsider.com - January 6 at 8:55 AM
Avista Pharma Solutions Expands Drug Product cGMP Manufacturing at Colorado SiteAvista Pharma Solutions Expands Drug Product cGMP Manufacturing at Colorado Site
www.businesswire.com - December 20 at 8:52 AM
Pharma-Bio Serv (PBSV) Upgraded at ValuEnginePharma-Bio Serv (PBSV) Upgraded at ValuEngine
www.americanbankingnews.com - December 2 at 9:50 PM

SEC Filings

Pharma-Bio Serv (OTCMKTS:PBSV) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Pharma-Bio Serv (OTCMKTS PBSV) Stock Chart for Thursday, April, 19, 2018

Loading chart…

This page was last updated on 4/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.